Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy (ACE)

NCT07548476 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT07548476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07548476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy (ACE)
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
September 3, 2026
Completion date
August 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced urothelial cancer, bladder cancer, metastatic bladder cancer, metastatic urothelial cancer, peripheral neuropathy, urothelial cancer